skip to content

Srinivasan, Piramal join Tata Sons as independent directors

Date:

Mumbai, Aug 25 (PTI) Tata Sons today appointed TVS MotorChairman Venu Srinivasan and Piramal group chief Ajay Piramalas non-executive directors on its board with immediate effect. Srinivasan is also Chairman of Sundaram-Clayton. He served as CII President during 2009-10, SIAM Presidentduring 1999-2001 and also as Chairman of the National SafetyCouncil. Srinivasan was conferred with the JRD Tata CorporateLeadership Award by the All India Management Association forhis contribution to leadership and management, and theJamsetji Tata Lifetime Achievement award by the Indian Societyfor Quality in 2004. A Padma Shri recipient, Srinivasan holds a degree fromthe College of Engineering, Chennai and a Master’s Degree inManagement from Purdue University, US. Piramal serves on the Harvard Business School’s board ofDean’s Advisors, and is also Chairman of Pratham, which claimsto be the world’s largest NGO in primary education. Piramal has a BSc from Bombay University and a Master’s inManagement Studies from the Mumbai-based Jamnalal BajajInstitute of Management Studies. PTI BEN RSYABKJMF

Previous article
Next article

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

IPL 2024: SRH Qualifies For Playoffs As Match Against Gujarat Abandoned Due To Rain

Sunrisers Hyderabad have officially became the third team to qualify for playoffs

Three Year Old Dead After Parent’s Forget Her In Car, Attend Wedding

As per the police, the incident occurred on Wednesday evening and the girl has been identified as Gorvika Nagar

IPL 2024: Toss Delayed In Sunrisers Hyderabad-Gujarat Titans Clash Due To Rain

It will be a crucial match for the Hyderabad-based franchise since they have to win the match to qualify for the playoffs of the IPL 2024

Another Rare Blood Disorder Linked To AstraZeneca Covid Vaccine Found

Researchers have found that the AstraZeneca vaccine sold in India under the brand name Covishield is linked to a rare blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)